Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19358884rdf:typepubmed:Citationlld:pubmed
pubmed-article:19358884lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:19358884lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:19358884lifeskim:mentionsumls-concept:C1801960lld:lifeskim
pubmed-article:19358884lifeskim:mentionsumls-concept:C2709248lld:lifeskim
pubmed-article:19358884lifeskim:mentionsumls-concept:C0162772lld:lifeskim
pubmed-article:19358884lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:19358884lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:19358884pubmed:issue1lld:pubmed
pubmed-article:19358884pubmed:dateCreated2009-6-2lld:pubmed
pubmed-article:19358884pubmed:abstractTextAcute hypoxia causes pulmonary vascular leak and is involved in the pathogenesis of pulmonary edema associated with inflammation, acute altitude exposure, and other critical illnesses. Reactive oxygen species, HIF-1, and VEGF have all been implicated in various hypoxic pathologies, yet the ROS-HIF-1-VEGF pathway in pulmonary vascular leak has not been defined. We hypothesized that the ROS-HIF-1-VEGF pathway has an important role in producing hypoxia-induced pulmonary vascular leak. Human pulmonary artery endothelial cell (HPAEC) monolayers were exposed to either normoxia (21% O(2)) or acute hypoxia (3% O(2)) for 24 h and monolayer permeability and H(2)O(2), nuclear HIF-1alpha, and cytosolic VEGF levels were determined. HPAEC were treated with antioxidant cocktail (AO; ascorbate, glutathione, and alpha-tocopherol), HIF-1 siRNA, or the VEGF soluble binding protein fms-like tyrosine kinase-1 (sFlt-1) to delineate the role of the ROS-HIF-1-VEGF pathway in hypoxia-induced HPAEC leak. Additionally, mice exposed to hypobaric hypoxia (18,000 ft, 10% O(2)) were treated with the same antioxidant to determine if in vitro responses corresponded to in vivo hypoxia stress. Hypoxia increased albumin permeativity, H(2)O(2) production, and nuclear HIF-1alpha and cytosolic VEGF concentration. Treatment with an AO lowered the hypoxia-induced HPAEC monolayer permeability as well as the elevation of HIF-1alpha and VEGF. Treatment of hypoxia-induced HPAEC with either an siRNA designed against HIF-1alpha or the VEGF antagonist sFlt-1 decreased monolayer permeability. Mice treated with AO and exposed to hypobaric hypoxia (18,000 ft, 10% O(2)) had less pulmonary vascular leak than those that were untreated. Our data suggest that hypoxia-induced permeability is due, in part, to the ROS-HIF-1alpha-VEGF pathway.lld:pubmed
pubmed-article:19358884pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:languageenglld:pubmed
pubmed-article:19358884pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:citationSubsetIMlld:pubmed
pubmed-article:19358884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19358884pubmed:statusMEDLINElld:pubmed
pubmed-article:19358884pubmed:monthJullld:pubmed
pubmed-article:19358884pubmed:issn1873-4596lld:pubmed
pubmed-article:19358884pubmed:authorpubmed-author:MajkaSusanSlld:pubmed
pubmed-article:19358884pubmed:authorpubmed-author:FloresSonia...lld:pubmed
pubmed-article:19358884pubmed:authorpubmed-author:McCordJoe MJMlld:pubmed
pubmed-article:19358884pubmed:authorpubmed-author:Nozik-GrayckE...lld:pubmed
pubmed-article:19358884pubmed:authorpubmed-author:SullivanTimTlld:pubmed
pubmed-article:19358884pubmed:authorpubmed-author:IrwinDavid...lld:pubmed
pubmed-article:19358884pubmed:authorpubmed-author:ForemanBenBlld:pubmed
pubmed-article:19358884pubmed:authorpubmed-author:WhiteMollyMlld:pubmed
pubmed-article:19358884pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:19358884pubmed:authorpubmed-author:BecklyGinnyGlld:pubmed
pubmed-article:19358884pubmed:authorpubmed-author:T...lld:pubmed
pubmed-article:19358884pubmed:authorpubmed-author:BaileyDamianDlld:pubmed
pubmed-article:19358884pubmed:authorpubmed-author:KlemmDwightDlld:pubmed
pubmed-article:19358884pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19358884pubmed:day1lld:pubmed
pubmed-article:19358884pubmed:volume47lld:pubmed
pubmed-article:19358884pubmed:ownerNLMlld:pubmed
pubmed-article:19358884pubmed:authorsCompleteYlld:pubmed
pubmed-article:19358884pubmed:pagination55-61lld:pubmed
pubmed-article:19358884pubmed:dateRevised2011-10-13lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:meshHeadingpubmed-meshheading:19358884...lld:pubmed
pubmed-article:19358884pubmed:year2009lld:pubmed
pubmed-article:19358884pubmed:articleTitleA potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxia-induced pulmonary vascular leak.lld:pubmed
pubmed-article:19358884pubmed:affiliationUniversity of Colorado Health Science Center, School of Medicine, Denver, CO 80262, USA. David.Irwin@ucdenver.edulld:pubmed
pubmed-article:19358884pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19358884pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19358884lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19358884lld:pubmed